Mindfulness-based cognitive therapy to improve stress and reduce sleep in patients with inflammatory bowel disease

Completed

• Conditions: Colitis Ulcerosa; Crohn's disease; Inflammatory bowel disease; 10017969; 10002861; 10024450

• Registration Number: NL-OMON49598
• Lead Sponsor: Radboud Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-10-03
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 142

Inclusion Criteria

Confirmed IBD diagnosis of Crohn*s disease (CD), Ulcerative colitis (UC) or
Indeterminate colitis (IC)
Current IBD remission (Calprotectin < 250 mg/kg) since at least three months
Hospital Anxiety and Depression Scale-score of ><=11, indicating at least mild
levels of psychological distress.
Age of 18 or older
Taking no IBD medication or on a stable dose of 5-ASA products,
immunosuppressive medication, or biologics for at least three months prior to
enrollment

Exclusion Criteria

Severe psychiatric disorders (e.g. acute suicidality, psychosis)
Current alcohol or drug dependency
Untreated anemia
Prior participation in an 8-week MBSR or MBCT-programme

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcome will be psychological distress according to the Hospital<br /><br>Anxiety and Depression Scale (HADS).</p><br>